Compare ABVX & MNDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABVX | MNDY |
|---|---|---|
| Founded | 2013 | 2012 |
| Country | France | Israel |
| Employees | 67 | N/A |
| Industry | | Computer Software: Prepackaged Software |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 7.4B |
| IPO Year | N/A | 2021 |
| Metric | ABVX | MNDY |
|---|---|---|
| Price | $115.56 | $74.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 25 |
| Target Price | $128.42 | ★ $174.92 |
| AVG Volume (30 Days) | 755.4K | ★ 2.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $20.70 |
| Revenue Next Year | $0.22 | $16.48 |
| P/E Ratio | ★ N/A | $34.38 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.77 | $68.68 |
| 52 Week High | $148.83 | $316.98 |
| Indicator | ABVX | MNDY |
|---|---|---|
| Relative Strength Index (RSI) | 47.24 | 36.51 |
| Support Level | $106.37 | $68.80 |
| Resistance Level | $131.27 | $80.58 |
| Average True Range (ATR) | 5.29 | 4.15 |
| MACD | -0.44 | 2.12 |
| Stochastic Oscillator | 38.97 | 43.68 |
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.
Monday.com is a work management platform allowing for increased collaboration and visibility across an organization. Delivered via a SaaS-based model, users can track progress across marketing and development initiatives, create and automate workflows, and manage IT approvals. Revenue is generated on a per-seat basis across several pricing tiers. As of fiscal 2024, the company had over 245,000 customers.